Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | %Female (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Cancer Drug Targets | journal | 1.789 | 103 | 89 | 255 | 9901 | 1288 | 238 | 4.31 | 111.25 | 36.86 | |
2 | Current Gene Therapy | journal | 1.565 Q2 | 80 | 45 | 141 | 5121 | 693 | 127 | 5.30 | 113.80 | 43.02 | |
3 | Current Alzheimer Research | journal | 1.509 Q1 | 103 | 120 | 254 | 9914 | 1139 | 241 | 3.98 | 82.62 | 44.31 | |
4 | CNS and Neurological Disorders - Drug Targets | journal | 1.492 Q1 | 96 | 123 | 237 | 9055 | 913 | 208 | 3.68 | 73.62 | 38.30 | |
5 | Current Topics in Medicinal Chemistry | journal | 1.409 Q1 | 133 | 233 | 510 | 22139 | 1975 | 440 | 3.77 | 95.02 | 36.31 | |
6 | Current Protein and Peptide Science | journal | 1.339 Q1 | 96 | 74 | 204 | 8257 | 600 | 179 | 2.23 | 111.58 | 43.38 | |
7 | Current Genomics | journal | 1.273 Q2 | 77 | 67 | 184 | 5787 | 595 | 175 | 3.01 | 86.37 | 35.09 | |
8 | Current Drug Abuse Reviews | journal | 1.169 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
9 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.082 Q1 | 52 | 24 | 80 | 3030 | 254 | 77 | 2.98 | 126.25 | 41.41 | |
10 | Current Stem Cell Research and Therapy | journal | 1.065 Q1 | 63 | 49 | 120 | 3616 | 471 | 114 | 3.33 | 73.80 | 38.93 | |
11 | Current Diabetes Reviews | journal | 1.034 Q2 | 68 | 49 | 129 | 5136 | 460 | 127 | 3.24 | 104.82 | 34.59 | |
12 | Current Aging Science | journal | 1.029 Q1 | 42 | 36 | 82 | 1981 | 259 | 80 | 3.30 | 55.03 | 42.73 | |
13 | Current Neurovascular Research | journal | 0.991 | 60 | 41 | 96 | 1746 | 356 | 96 | 3.31 | 42.59 | 35.16 | |
14 | Current Vascular Pharmacology | journal | 0.975 Q1 | 69 | 107 | 217 | 8016 | 744 | 205 | 3.15 | 74.92 | 27.27 | |
15 | Mini-Reviews in Medicinal Chemistry | journal | 0.941 Q1 | 107 | 140 | 364 | 12246 | 1255 | 356 | 3.41 | 87.47 | 35.18 | |
16 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.819 Q2 | 63 | 40 | 101 | 3682 | 226 | 97 | 1.69 | 92.05 | 45.45 | |
17 | Recent Patents on CNS Drug Discovery | journal | 0.803 Q2 | 36 | 25 | 58 | 3322 | 179 | 58 | 3.03 | 132.88 | 38.10 | |
18 | Current Neuropharmacology | journal | 0.799 Q2 | 103 | 35 | 170 | 4661 | 494 | 162 | 2.30 | 133.17 | 30.39 | |
19 | Recent Patents on Drug Delivery and Formulation | journal | 0.783 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
20 | Reviews on Recent Clinical Trials | journal | 0.683 Q2 | 35 | 42 | 79 | 2507 | 186 | 79 | 2.00 | 59.69 | 35.81 | |
21 | Clinical Practice and Epidemiology in Mental Health | journal | 0.645 Q2 | 58 | 25 | 66 | 1220 | 149 | 64 | 2.00 | 48.80 | 51.09 | |
22 | Combinatorial Chemistry and High Throughput Screening | journal | 0.607 Q2 | 70 | 87 | 293 | 4972 | 632 | 261 | 1.99 | 57.15 | 28.79 | |
23 | Current Clinical Pharmacology | journal | 0.600 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
24 | Open Respiratory Medicine Journal | journal | 0.595 Q2 | 25 | 23 | 48 | 974 | 83 | 44 | 2.04 | 42.35 | 34.74 | |
25 | Infectious Disorders - Drug Targets | journal | 0.593 Q2 | 61 | 47 | 145 | 3616 | 275 | 129 | 1.89 | 76.94 | 36.72 | |
26 | Current Cardiology Reviews | journal | 0.553 Q2 | 58 | 43 | 123 | 2889 | 219 | 117 | 1.56 | 67.19 | 17.09 | |
27 | Current Computer-Aided Drug Design | journal | 0.510 Q2 | 32 | 29 | 76 | 1626 | 134 | 70 | 1.80 | 56.07 | 26.76 | |
28 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.502 Q2 | 43 | 34 | 78 | 3271 | 168 | 78 | 1.96 | 96.21 | 32.65 | |
29 | Open Cardiovascular Medicine Journal | journal | 0.456 Q2 | 32 | 25 | 107 | 950 | 188 | 103 | 1.96 | 38.00 | 29.20 | |
30 | Current Nanoscience | journal | 0.453 Q2 | 52 | 135 | 296 | 4918 | 504 | 292 | 1.52 | 36.43 | 34.61 | |
31 | Recent Patents on Inflammation and Allergy Drug Discovery | journal | 0.434 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
32 | Current Drug Safety | journal | 0.428 Q2 | 41 | 63 | 136 | 2743 | 228 | 124 | 1.49 | 43.54 | 35.16 | |
33 | Current Nutrition and Food Science | journal | 0.420 Q3 | 32 | 38 | 94 | 2353 | 114 | 90 | 1.00 | 61.92 | 52.99 | |
34 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.412 Q2 | 45 | 23 | 83 | 1226 | 111 | 77 | 1.38 | 53.30 | 37.50 | |
35 | Anti-Infective Agents | journal | 0.399 Q3 | 26 | 27 | 43 | 1255 | 59 | 40 | 1.22 | 46.48 | 34.00 | |
36 | Current Radiopharmaceuticals | journal | 0.392 Q3 | 32 | 45 | 95 | 2173 | 99 | 86 | 1.23 | 48.29 | 33.11 | |
37 | Current Chemical Biology | journal | 0.378 Q2 | 26 | 27 | 80 | 2346 | 141 | 77 | 0.63 | 86.89 | 35.29 | |
38 | Drug Metabolism Letters | journal | 0.374 Q2 | 31 | 29 | 112 | 1010 | 140 | 111 | 1.39 | 34.83 | 44.35 | |
39 | Open AIDS Journal | journal | 0.369 Q3 | 22 | 39 | 39 | 1274 | 28 | 39 | 0.74 | 32.67 | 51.82 | |
40 | Current Pharmacogenomics and Personalized Medicine | journal | 0.368 Q4 | 20 | 41 | 89 | 2194 | 140 | 72 | 1.24 | 53.51 | 44.66 | |
41 | Recent patents on food, nutrition & agriculture | journal | 0.339 Q3 | 33 | 24 | 72 | 1867 | 120 | 72 | 1.33 | 77.79 | 55.36 | |
42 | Current Immunology Reviews | journal | 0.332 Q3 | 23 | 36 | 128 | 3012 | 130 | 118 | 1.14 | 83.67 | 39.78 | |
43 | Current Psychiatry Reviews | journal | 0.296 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
44 | Current Medical Imaging | journal | 0.261 Q3 | 37 | 37 | 113 | 2613 | 73 | 101 | 0.57 | 70.62 | 23.76 | |
45 | Current Signal Transduction Therapy | journal | 0.246 Q3 | 22 | 34 | 95 | 3349 | 59 | 88 | 0.49 | 98.50 | 43.93 | |
46 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.235 Q3 | 17 | 34 | 78 | 2748 | 37 | 70 | 0.39 | 80.82 | 28.45 | |
47 | Current Cancer Therapy Reviews | journal | 0.226 Q3 | 17 | 39 | 94 | 2649 | 57 | 93 | 0.56 | 67.92 | 35.37 | |
48 | Current Pediatric Reviews | journal | 0.212 Q3 | 33 | 46 | 112 | 2726 | 57 | 103 | 0.49 | 59.26 | 54.35 | |
49 | Current Hypertension Reviews | journal | 0.211 Q3 | 27 | 39 | 105 | 2954 | 48 | 100 | 0.47 | 75.74 | 31.25 | |
50 | Open Biomedical Engineering Journal | journal | 0.211 Q3 | 28 | 13 | 46 | 372 | 55 | 44 | 1.07 | 28.62 | 16.67 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®